TY - JOUR
T1 - “It's not just the hit itself”
T2 - the social practice of injecting drug use among gay and bisexual men in Australia
AU - Schroeder, Sophia E.
AU - Bourne, Adam
AU - Doyle, Joseph
AU - Stoove, Mark
AU - Hellard, Margaret
AU - Pedrana, Alisa
N1 - Funding Information:
MH and AP receive investigator-initiated research funding from Gilead Sciences, Abbvie and Merck. JD’s institution has received investigator-initiated research funding from Gilead and AbbVie and consultancies from Gilead and AbbVie. AP and her institution have received consultancies and travel honoraria from Gilead. AB’s institution has received investigator-initiated research funding from ViiV.
Funding Information:
SS is the grateful recipient of a Monash Research Training Program (RTP) stipend and Monash International Tuition Scholarship. The Burnet Institute is supported by the Victorian Operational Infrastructure Support Program. We would like to thank the LGBTQ+ community organisations, Garret Prestage and the FLUX study team in UNSW, and the coEC, Extend-C and SuperMIX study teams at Burnet Institute and Alfred Health for assisting with recruitment. Most importantly, we would like to thank the men who participated in this research.
Funding Information:
The Burnet Institute is supported by the Victorian Operational Infrastructure Support Program. M.S. is supported by a NHMRC senior research fellowship. SS is supported by Monash Research Training Scholarship and International Tuition Scholarship.
Funding Information:
This research received funding from the following sources.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/5
Y1 - 2022/5
N2 - Background: Injecting drug use is purportedly more common among gay and bisexual men (GBM) than the general Australian population. Approaches designed to support the wellbeing of people who inject drugs may not be effective for GBM who inject, due to divergent settings, substances, and/or symbolism. We sought to identify the critical elements shaping injecting among GBM as a social practice and the implications for health and psychosocial wellbeing. Methods: We conducted 19 in-depth interviews with GBM in Australia with lifetime experience of injecting drug use, adopting the Frameworks Method for data analysis. Framed by social practice theory, transcripts were coded to delineate the constituent material, competency, and meaning elements of GBM's injecting practices. We developed themes encompassing the dynamic interrelationship between practice elements and wellbeing aspects. Results: Of 19 participants interviewed (aged 24–60 years), 17 identified as gay, two as bisexual. Injecting histories ranged from 2–32 years; most injected methamphetamine (n = 18). Injecting involved the integration of sexual function with substances and injecting skills in dyadic/communal settings. Beyond traditional harm reduction aspects, ‘safe injecting’ concerned trustworthiness of fellow practitioners, preventing addiction, and maintaining a solid self-concept. Injecting occurred as a dyadic/communal practice, in which an uneven distribution of materials (substances, sexual capital) and competencies (self-injecting) influenced risk and power dynamics. Pleasurable meanings of belonging, desirability and self-actualisation – gained from communities of practice – conflicted with injecting-related stigma, social dependencies, and fear of harms to body, mind, and sense of self. Conclusion: Injecting is a heterogenous practice, including among GBM. Shifting configurations of its composite elements influence GBM's perceptions and experiences of pleasure, risk, and harms. Efforts to support their wellbeing should take a dyadic/communal approach and seek to rectify the uneven distribution of material and competency elements in these settings.
AB - Background: Injecting drug use is purportedly more common among gay and bisexual men (GBM) than the general Australian population. Approaches designed to support the wellbeing of people who inject drugs may not be effective for GBM who inject, due to divergent settings, substances, and/or symbolism. We sought to identify the critical elements shaping injecting among GBM as a social practice and the implications for health and psychosocial wellbeing. Methods: We conducted 19 in-depth interviews with GBM in Australia with lifetime experience of injecting drug use, adopting the Frameworks Method for data analysis. Framed by social practice theory, transcripts were coded to delineate the constituent material, competency, and meaning elements of GBM's injecting practices. We developed themes encompassing the dynamic interrelationship between practice elements and wellbeing aspects. Results: Of 19 participants interviewed (aged 24–60 years), 17 identified as gay, two as bisexual. Injecting histories ranged from 2–32 years; most injected methamphetamine (n = 18). Injecting involved the integration of sexual function with substances and injecting skills in dyadic/communal settings. Beyond traditional harm reduction aspects, ‘safe injecting’ concerned trustworthiness of fellow practitioners, preventing addiction, and maintaining a solid self-concept. Injecting occurred as a dyadic/communal practice, in which an uneven distribution of materials (substances, sexual capital) and competencies (self-injecting) influenced risk and power dynamics. Pleasurable meanings of belonging, desirability and self-actualisation – gained from communities of practice – conflicted with injecting-related stigma, social dependencies, and fear of harms to body, mind, and sense of self. Conclusion: Injecting is a heterogenous practice, including among GBM. Shifting configurations of its composite elements influence GBM's perceptions and experiences of pleasure, risk, and harms. Efforts to support their wellbeing should take a dyadic/communal approach and seek to rectify the uneven distribution of material and competency elements in these settings.
KW - Gay and bisexual men
KW - Injecting drug use
KW - Party and play
KW - Sexuality
KW - Social practice theory
KW - Stigma
UR - http://www.scopus.com/inward/record.url?scp=85125515881&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2022.103642
DO - 10.1016/j.drugpo.2022.103642
M3 - Article
C2 - 35247865
AN - SCOPUS:85125515881
SN - 0955-3959
VL - 103
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 103642
ER -